Integrated Strategy for Hit-to-Lead Optimization: The ‘DOTS’ approach

webinar

Thu, 27 Oct 2022, 16:00 CEST (Berlin)

Dr. Xavier Morelli, Centre de Recherche en Cancérologie de Marseille (CRCM), France

Integrated Strategy for Hit-to-Lead Optimization: The ‘DOTS’ approach

In recent decades, the identification of hits has been greatly facilitated by advances in high throughput screening (HTS) and the design of chemical libraries. It would be wishful to optimize the automation of the ‘hit-to-lead’ (H2L) process. Xavier will present an integrated strategy for the H2L optimization phase and the automated design of chemical probes called Diversity Oriented Target-Focused Synthesis (DOTS and CovaDOTS) approach.
In the ‘DOTS’ approach, a focused virtual library is generated by combining an activated fragment — corresponding to a substructure that binds to a target — with a collection of functionalized chemical blocks, using in silico encoded relevant chemical reactions. Target-specific compounds are selected by virtual screening, followed by in vitro synthesis and evaluation using a robotic platform. The proof of concept was successfully completed by the optimization of bromodomain inhibitors that lead to the validation of several compounds with an affinity that had improved by several orders of magnitude. The proposed process can be implemented in academic environments or biotechnology companies that desire an automation of these processes.

 

Register and tune in for a very exciting webinar.

1 Hoffer L. et al. J. Med. Chem. 2018 Jul 12;61(13):5719-5732; Carrasco K. et al., J. Med. Chem. 2022 Apr 14;65(7):5660-5674 

2 Hoffer L., et al. J. Chem. Inf. Model. 2019 2019 Apr 22;59(4):1472-1485

Current news

category
Software
Mode Highlight: SeeSAR's Idea Factory
May 28, 2025 11:06 CEST
We’re excited to spotlight the Inspirator Mode in SeeSAR – a feature designed to supercharge your creativity during hit and lead discovery. Whether you’re a medicinal chemist or computational expert, Inspirator highlights the most promising molecular decorations across hundreds of thousands of conformations. With just a few clicks, it guides...
Read on
category
Challenge
Winners of the Scientific Challenge Spring 2024: Diana Assis And Vicente Ledesma with Molecular Photoswitches Targeting The Orexin System In Alzheimer's Disease
May 6, 2025 14:56 CEST
We are happy to announce that Diana Assis and Vicente Ledesma from the Faculty of Pharmacy, University of Lisbon, Portugal, are the winners of the BioSolveIT Scientific Challenge Spring 2024. Their research explores the potential of molecular photoswitches targeting orexin receptors 1 and 2 (OX1R and OX2R) as a novel...
Read on
category
Events
Drug Discovery Events in Spring and Summer 2025: Meet the BioSolveIT Staff
April 15, 2025 15:01 CEST
The upcoming conference season is packed with opportunities for anyone passionate about small molecule drug discovery and computational chemistry. Whether you’re looking to connect with like-minded scientists, stay up to date on the latest innovations, or simply not sure which events to attend this year—our curated list of conferences is...
Read on